Category Archives: Anti-Aging Medicine

NEW YORK, Oct. 24, 2019 (GLOBE NEWSWIRE) -- According to the market research report published by P&S Intelligence, the globalanti-aging and skin rejuvenation energy-based aesthetic devices marketwas valued at $872.0 million in 2018, which is projected to reach $1,612.2 million by 2024, progressing at a CAGR of 11.2% during the forecast period (20192024). Based on indication, the skin rejuvenation category is expected to witness faster growth, at a CAGR of 11.5%, during the forecast period, owing to the fact that such devices are more technologically advanced and widely adopted for skin rejuvenating procedures, which is a major reason for the categorys growth.

Based on technology, laser-based devices are expected to hold the largest share, of 28.7%, in the anti-aging and skin rejuvenation energy-based aesthetic devices market in 2024, owing to the rising awareness about the better safety profile of laser-based devices in comparison to treatments based on other types of energy, such as plasma.

Get a Free Sample Copy of this Report at: https://www.psmarketresearch.com/market-analysis/anti-aging-and-skin-rejuvenation-energy-based-aesthetic-devices-market/report-sample

Based on end user, dermatologists/cosmetologists held the largest share, of 54.9%, in 2018 as well as are predicted to record the fastest growth in the global market during the forecast period. This is owing to the surging prevalence of skin diseases and rising awareness about their management through aesthetic procedures.

Direct is likely to be the faster growing distribution channel category, witnessing a CAGR of 11.7%, during the forecast period. This can mainly be ascribed to the growing trend of online shopping, specifically for home-use aesthetic products.

North America is expected to account for the largest share in the anti-aging and skin rejuvenation energy-based aesthetic devices market by 2024, followed by Europe. Together, North America and Europe are expected to account for a 65.3% market share in 2024. This can be mainly attributed to the presence of established players and rising geriatric population, along with the surging consciousness among people about their appearance.

Browse report overview with detailed TOC on"Anti-Aging and Skin Rejuvenation Energy-Based Aesthetic Devices Market Research Report: By Technology (Laser-Based, Light-Based, Electromagnetic Energy-Based, Ultrasound-Based, Plasma Energy-Based), Indication (Skin Rejuvenation, Anti-Aging), Application (Skin Tightening, Fine Line & Wrinkle Reduction, Scar Treatment, Oxygenation), Distribution Channel (Direct, Indirect), End User (Dermatologists/Cosmetologists, Beauticians, Clinicians), Geographical Outlook (U.S., Canada, Italy, Germany, France, Spain, U.K., Japan, India, China, Australia, Brazil, Mexico, Saudi Arabia, South Africa) Global Industry Trends and Growth Forecast to 2024"at: https://www.psmarketresearch.com/market-analysis/anti-aging-and-skin-rejuvenation-energy-based-aesthetic-devices-market

Other regions, which include APAC, LATAM, and MEA, also hold considerable shares in the anti-aging and skin rejuvenation energy-based aesthetic devices market on account of the rapid expansion of the aesthetics industry due to globalization, which is, in turn, increasing the awareness among consumers about alternatives to surgical aesthetic treatments.

In 2018, Japan held a 23.3% share in the APAC market, and it is predicted to prosper at a CAGR of 12.5% during the forecast period. A surge in the aging population and increasing awareness about non-invasive aesthetic procedures are some of the key factors propelling the growth of the market in the country.

Brazil is projected to be the fastest-growing anti-aging and skin rejuvenation energy-based aesthetic devices market in the LATAM region during the forecast period. In Brazil, people are thought of as having the right to beauty. The government supports this right by subsidizing nearly half a million surgeries every year and offering plastic surgeries at public hospitals either for free or at a low cost. Due to the low cost, more people are becoming inclined toward getting these procedures done to enhance their beauty.

Make Enquiry Before Purchase at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=anti-aging-and-skin-rejuvenation-energy-based-aesthetic-devices-market

The anti-aging and skin rejuvenation energy-based aesthetic devices market is fragmented in nature with the presence of giant players, such as Cynosure Inc., Alma Lasers Inc., Syneron Medical Ltd., Lumenis Ltd., Cutera Inc., Solta Medical Inc., Candela Corporation, Sciton Inc., and EL.EN. S.p.A.

The players in the anti-aging and skin rejuvenation energy-based aesthetic devices market are adopting product launches and mergers and acquisitions as a key strategy to maintain their position. For example, in March 2019, Sciton Inc. unveiled the latest version of its flagship platform, JOULE X, at the annual American Society for Laser Medicine and Surgery Meeting (ASLMS), held on March 2731 in Denver, Colorado. JOULE X is a multi-device platform with customizable laser and light performance.

Some other important players operating in the global anti-aging and skin rejuvenation energy-based aesthetic devices market are Allergan Plc, Merz Pharma GmbH & Co. KGaA, Hologic Inc., Bausch Health Companies Inc., Venus Concept Ltd., EndyMed Medical Ltd., LightStim Quasar Biotech Inc., and TRIA Beauty Inc.

More Reports of Life Sciences By P&S Intelligence

MEA Energy-Based Aesthetic Devices MarketSaudi Arabia held the largest share in the MEA energy-based aesthetic devices market in 2018, followed by Turkey. Together, Saudi Arabia and Turkey are expected to account for a 32.4% market share by 2024.

https://www.psmarketresearch.com/market-analysis/mea-energy-based-aesthetic-devices-market

Energy-Based Aesthetic Devices Market

Globally, the North American energy-based aesthetic devices market is expected to account for around 40% share by 2024. This can be mainly attributed to the presence of established players, and increase in the adoption of energy-based aesthetic devices in the region.

https://www.psmarketresearch.com/market-analysis/energy-based-aesthetic-devices-market

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:P&S IntelligenceToll-free: +1-888-778-7886 (USA/Canada)International: +1-347-960-6455Email: enquiry@psmarketresearch.comWeb: https://www.psmarketresearch.com

Connect with us: LinkedIn|Twitter|Facebook

See more here:

Anti-Aging and Skin Rejuvenation Energy-Based Aesthetic Devices Market is Poised to Hit $1612.2 Million by 2024: P&S Intelligence - GlobeNewswire

Non-surgical regenerative cell-based treatment uses the bodys natural healing ability to repair damaged bones, muscles, cartilage, tendons and ligaments.Knee injuries are painful and often patients are unable to walk. Our treatment protocol always uses products following FDA guidelines.Injections done with ultrasound guided needle recognition capability to ensure safety as well target the area needing treatment. Plasma; Alpha-2-Macroglobulim (A2M) is the new biologic treatment for your arthritic knee (osteoarthritis)When your hips hurt, or your knee is stiff, or your back is throbbing, that means your joint is bone on bone and there is no lubrication to ease movement.Regenerative medicine giving new hope to patients suffering from painful joint injuries such as knee, shoulder and hip with a chance to live a pain free life.Regenerative cell-based ultrasound guided injection now available to treat pain associated with joint injury. There are indications that it reduces the pain and swelling of the joints and helps lubricating and improve movements.Commonly Treated Conditions: Osteoarthritis of the Hips, Knee, and Shoulders Rotator Cuff tears of the Shoulder Meniscus, ACL and PCL tears of the kneeOur stem cell treatment using your own stem cells and with using imaging guidance ensures precise injection of stem cell, it is a highly-specialized practice.Besides treating above injuries we have advance stem cell micro-needling treatment for the following: Cell-based PRP Hair Restoration combining micro-needling with growth factors and hair follicles voluma vitamins plus BLotinyl T1, Biotin, Anti-aging and Kopexil. Non-toxin facial renewal Anti-Aging APGF Advanced Peptide Micro-needling PRP, Dual Anti-Aging Ampoules for deep hydration, more collagen to reduce wrinkles and firm skin.Dr. Ibrahim is the staff physician at Valencia Medical Center specializing in regenerative medicine, pain management, and rejuvenation. Call for a consultation at 661-222-9117.

See the article here:

Hormones Control your Health, Mood and Behavior A balanced hormone means happier, healthier life and success in career and relationship. - Magazine of...

Medical aesthetics is an area of medicine, dealing with aesthetics, well-being, peripheral appearance, noticeable skin changes, and image of the patient. Medical aesthetics include high-technology skin care procedures that denote the fusion of beauty and healthcare services. Procedures for these include the use of ground-breaking technologies to increase the aesthetics of the person. The demand for anti-aging products and procedures is growing significantly, owing to the growing focus of patients aged 50 years and above to look young and improve their appearance.

Growth in this market is mainly driven by the growing adoption of minimally invasive and noninvasive aesthetic procedures, rising adoption among geriatric individuals, increasing public awareness about cosmetic procedures, the availability of technologically advanced & user-friendly products, and the increasing demand for aesthetic treatments among men.

Get Sample copy of this Report @: https://www.researchnreports.com/request_sample.php?id=77005

Medical Aesthetic Devices Market Key Segments:

Medical Aesthetic Devices Market by Product:

Medical Aesthetic Devices Market by Application:

Medical Aesthetic Devices Market by End User:

Companies Profiled in this Report includes, Allergan PLC, Solta Medical Inc., Syneron Medical Ltd., Cynosure Inc., Lumenis Ltd., Johnson & Johnson, Merz Pharma GmbH & Co., Alma Lasers Ltd.

In product type segment, the aesthetic laser devices are growing at the highest CAGR. Aesthetic laser devices are growing because these lasers work for cosmetics application by a process called selective photothermolysis i.e. the modulation of the frequency of light for the generation of heat in the areas where it is intended to be applied. For achieving the desired aesthetic effect the wavelength of light should perfectly synchronize with the color of the target.

In Application segment, the anti-aging and wrinkles segment is growing with the highest CAGR, because people are more conscious about their look or appearance especially when it comes to their body and hence wrinkles and antiaging application area is dominating the medical aesthetics market as it provides better result in terms of beautiful look.

In the end user segment, the cosmetic centers segment is growing with the highest CAGR because of the high awareness of the people and exclusive cosmetics services are provided in this sector.

Get Discount on this Premium Report @: https://www.researchnreports.com/ask_for_discount.php?id=77005

Key Questions Answered in This Report:

For More Information: https://www.researchnreports.com/enquiry_before_buying.php?id=77005

See the article here:

Unexpected Growth Seen in Medical Aesthetics Market Global Forecast to 2025 with Key Players Allergan PLC, Solta Medical, Syneron Medical, Cynosure...

The British Council and the British Embassy, Israel, have given the go-ahead to seven, new, three-year bilateral scientific projects in the field of research on ageing. The work will be carried out by top institutions in the UK and Israel.

The projects will be awarded nearly 2.8 million in total from BIRAX, a 10 million programme to support cutting edge UK-Israeli research.

BIRAX Ageing will look at the effects of ageing on human health, and the use of precision medicine and big data in ageing research. It will bring together scientists from the Hebrew University, Hadassah Medical Centre, Tel Aviv University, Tel Aviv Sourasky Medical Centre, University of Oxford, University of Cambridge, Kings College London, and Queens University Belfast.

The projects will focus on various aspects of ageing and how it affects diabetes, vascular disease, neuro-degenerative disease such as Multiple Sclerosis, brain imaging, as well as the use of technology for macular disease research.

British Ambassador to Israel, Mr. Neil Wigan said:

I am excited that seven new projects have been selected for the first call of BIRAX Ageing, the latest phase of our flagship science research programme. These cutting-edge research collaborations not only position the UK and Israel at the forefront of ageing research world-wide, but also reaffirm the close connection between British and Israeli academic communities and establishments. Through these meaningful and sustainable collaborations, we can together tackle universal ongoing challenges.

BIRAX Ageing research looks at the global challenges of ageing, bringing together world-class and complementary scientific capabilities to promote healthy ageing. It aims to establish and grow a substantial new academic community and support ground-breaking collaborative research in the field of ageing, funding both research mobility and joint research projects over the next five years. This crucial research will be generously supported by the Pears Foundation, The Israel Ministry of Science and Technology, The Parasol Foundation Trust, Charles Wolfson Charitable Trust, The Rosetrees Trust, Diabetes UK, The British Heart Foundation, and MS Society.

Sir Trevor Pears, Executive Chair of the Pears Foundation, added:

Since its establishment in 2011, the BIRAX Initiative has earned its excellent reputation for successfully nurturing UKIsrael scientific exchange for the advancement of knowledge. We are proud to have been the founding partner of this important initiative, which will have an enduring impact and legacy, and are delighted to be part of a family of committed partners.

BIRAX was initiated 8 years ago by the British Council, British Embassy in Israel and the UK Science and Innovation Network in collaboration with the Pears Foundation as a founding partner. So far, BIRAX has funded 19 research projects tackling some of the worlds most challenging health conditions and diseases by employing pioneering regenerative medicine and stem cell therapies and using the most advanced and cutting-edge technologies. The ground-breaking science has been made possible through the generous support of a broad family of partners and supporters including the Israel Ministry of Science and Technology, the British Heart Foundation, JDRF, MS Society, Parkinsons UK, Alzheimers Society, the Medical Research Council, The Parasol Foundation Trust, The Rosetrees Trust, Weizmann UK, Clore Foundation Israel, Charles Wolfson Charitable Trust, The Wolfson Foundation, The Maurice and Vivienne Wohl Philanthropic Foundation, The Kahn Foundation, UJIA, Celia and Edward Atkin, The Sheila and Denis Cohen Charitable Trust, The Barbara and Stanley Fink Foundation, and The Glycobiology Institute of Oxford University.

Principal Investigators: Professor Lynne Cox, University of Oxford Professor Rivka Dresner Pollak, Hadassah Medical Center

The overall aim of this research is to understand bone fragility in ageing patients with type 1 diabetes who are currently at high risk of bone fracture and premature death, and to develop new treatments.

Principal Investigators: Professor Heidi Johansen-Berg, University of OxfordProfessor Yaniv Assaf, Tel Aviv University

The project will explore neurodegenerative processes in age related disease such as dementia by understanding the processes behind healthy brain ageing. Owing to dramatic developments in brain imaging methods for providing quantitative measures of brain microstructure, in particular, in Prof Assafs lab in Tel Aviv, these methods could be particularly powerful ways to detect subtle changes in brain structure occurring with ageing, providing early indicators of age-related neurodegeneration. No database of microstructural imaging yet exists.

This project aims to create the first database of microstructural imaging and to initiate a brain database in Israel.

Principal Investigators: Professor Robin Franklin, University of CambridgeDr Amnon Buxboim, Hebrew University of Jerusalem

This project seeks to find answers that will provide clues as to how the effects of age might be reversed therapeutically. It will examine how the brain is able to induce harmful in central nerve system stem cells, and how are the physical signals of the brain transmitted to a central nerve system stem cell to change its function.

Principal Investigators: Professor Manuel Mayr, Kings College London Professor Eli Keshet, Hebrew University of Jerusalem

This project proposes a novel anti-ageing approach to combat age-associated deterioration of vascular function. The knowledge gained in the project will be leveraged for the development of new anti-aging treatments.

Principal Investigators: Professor Masashi Narita, University of Cambridge Professor Ittai Ben-Porath, Hebrew University of Jerusalem

This project addresses in depth the roles of beta-cell senescence in aging and diabetes. The researchers aim to uncover whether beta-cell senescence contributes to, or, alternatively acts to counteract diabetes.

Principal Investigators: Professor Tunde Peto, Queens University Belfast Professor Anat Loewenstein, Tel Aviv University

This project aims to investigate the performance of new automated software algorithms to monitor AMD and detect progression, towards implementation in routine patients management; and to investigate the potential for machine learning to identify factors and biomarkers associated with long-term AMD treatment response.

See more here:

2.8 million awarded to fund projects by British and Israeli scientists - GOV.UK

Express News Service

BENGALURU: Started in 1998, Inxs medical centre for Obesity is a centre of solace for all those who suffer from body weight. Dr Keerthi Patel and Dr Sangeetha Patel, the doctor duo who were working in Sri Jayadeva Institute of Cardiology as junior doctors after graduating from Sri Siddartha Medical College -Bangalore University, developed the solution to address the issue of obesity. Dr Keerthi R Patel speaks about their solutions and how obesity is one of the leading causes for heart disease and prevention is key.Tell us about the origin of Inxs Medical centre.

After finishing our diploma in Practical Dermatology from Cardiff (UK) and undergoing training in Mesotherapy in Paris (France), we pioneered in the field of Mesotherapy and launched treatments for the first time in India.

Subsequently, we worked and trained in Paris in the field of obesity management and launched Carboypentherapy in India. Later, we launched Cryolipolysis again for the first time here and after being in the obesity management field, we simultaneously launched the anti-aging section after successfully training in Brussels for the same.

What are the main services?Body sculpting injections, oral drops for weight loss, absolute fat loss treatments, stem cell-based face lifts, laser for pigmentation and mini-face lift, hair removal with light-based device, injections for skin colour change, nose shape changing procedure and hair growth injections.

How has it grown over the years?Since Inxs antiaging clinique is a well-known centre having a reputation for world-class treatment which are affordable and result-oriented, there is a good demand. The changing lifestyles have definitely made people aware of the latest developments in the field of cosmetology and anti-aging medicine and they are constantly on the lookout for such facilities in India rather than going abroad.

How many centres do you operate? Are you planning new ones?As of now, we operate only at Inxs Antiaging Clinique in Bengaluru as we believe in personalised treatment to patients, be it popular Bollywood stars who regularly visit us or local TV stars, or those who are looking for some makeovers.In terms of treatment, are you on par with international standards?We are qualified dermatologists and trained internationally. Over the last 20 years of clinical practice, we have treated over 10,000 cases with almost 95% success rate (5% owing to lack of follow-up and patients not following instructions). Inxs was chosen as the venue for the makeover centre for all the participants of Femina Diva 2018.

See the rest here:

Endeavour to change the face of India - The New Indian Express

We cant avoid aging. Every passing minute brings us one minute closer to the end. Not a pleasant thought. So, it is little wonder that the term anti-aging has been seized by marketers of various cosmetics, health supplements, exotic juices and dietary regimens. Anti-aging medicine is a growing field with numerous biotech companies working on drugs designed to combat the aging process.

The quest for immortality, of course, is not new. The ancient alchemists sought to turn base metals like lead into gold in order to find the secret of golds immortality. After all, the metal would not tarnish, it maintained its beautiful sheen and seemed to last forever. If they could find its magic, they could perhaps apply it to humans. But they never did find the secret. Lead is still lead and the alchemists are long dead.

This is not to say that there are not some intriguing possibilities that may help slow down the clock. As we age, an increasing number of our cells enter a stage of senescence in which they no longer divide and begin to release chemicals that cause inflammation resulting in damage to tissues. A buildup of senescent cells, sometimes called zombie cells, is a hallmark of aging. Can anything be done to prevent this buildup? Possibly. At least in mice. When researchers at the Mayo Clinic injected just a small number of senescent cells into young mice, their speed, endurance and strength eroded to that seen in a senior mouse in just a few weeks. When the mice were then treated with desatinib and quercetin, a combination of drugs known to destroy senescent cells, they recovered most of their lost physical capabilities within two weeks! Quite dramatic! But mice are not people, and while quercetin is a safe compound extracted from apple peel, desatinib is a very expensive leukemia drug with loads of side effects. Still, this experiment is a proof of principle, demonstrating that destroying senescent cells with senolytics is worthy of exploration.

However, slowing aging may not be a matter of what we do, but what we dont do. It may be that if we want to live longer, all we have to do is eat less. Calorie restriction has been the only sure-fire way that scientists have found to slow aging in animals from rodents to monkeys and now we are beginning to accumulate data that suggests this applies to humans, as well. The idea that less is more when it comes to eating is not new. Hippocrates noted that fat people were more likely to die suddenly than slender ones, and Avicenna, the famed Persian philosopher and physician, suggested that the elderly should eat less than when they were younger.

Venetian nobleman Luigi Cornaro may have been the first to put a restricted calorie diet to a test in the 17th century when he came to believe that his health was deteriorating due to excessive partaking of food, drink and sex. He then restricted himself to no more than 350 grams of food a day and 400 mL of wine and lived to the ripe old age of 98. He documented his regimen in his book Discourses On the Temperate Life and described how the changes he made in his lifestyle allowed him to remain in vigorous health well into old age.

Today, members of the Calorie Restriction Society that has the goal of increasing longevity are following in Cornaros footsteps and are acting as human guinea pigs. They consume no more than 2,000 calories per day, which is just over half of what an average North American wolfs down. They dont do this, though, by eating half servings of hamburger, fries or pizza. They do it by following a diet high in whole grains, fruits, vegetables, beans and fish. And according to a study published in the Journal of the American College of Cardiology, the austere regimen is paying off. Researchers examined the heart function of 25 members of the Calorie Restriction Society, and to their amazement found that the hearts functioned like those of people 15 years younger. But permanent hunger is not appealing.

What is appealing, however, is taking a deep dive into the science of aging. That is just what we will do this year at our annual Trottier Public Science Symposium, one of McGills largest annual public events. We have invited three expert speakers to address humans Longing for Longevity. On Tuesday, Oct. 22, Harvard Professor of Genetics David Sinclair, a world leader in aging research, will discuss how aging may be a treatable disease, and cosmetic chemist Kelly Dobos will scrutinize claims made by producers of anti-aging cosmetics. On Wednesday, Oct. 23, Ruth Westheimer, psychosexual therapist, author and pioneer of radio and television programs dealing with sexual issues will speak on Sex After 50. (Spoiler: there is.)

The symposium will take place at 7 p.m. both days at the Centre Mont Royal, 1000 Sherbrooke St. West. Admission is free. Arrive early.

joe.schwarcz@mcgill.ca

Joe Schwarcz is director of McGill Universitys Office for Science & Society (mcgill.ca/oss). He hosts The Dr. Joe Show on CJAD Radio 800 AM every Sunday from 3 to 4 p.m.

Read the rest here:

The Right Chemistry: Looking for the secrets to longevity - Montreal Gazette